December 12, 2024 12:57 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Devendra Fadnavis meets PM Modi amid suspense over Maharashtra portfolio allocation | Congress wants to deviate the issue of Sonia Gandhi-George Soros link: JP Nadda | Bengaluru techie suicide: Atul Subhash's family demanded Rs. 10 lakh as dowry leading to my father's death, claims estranged wife | Syria rebels torch tomb of ousted president Bashar al-Assad's father | Donald Trump vows to eliminate birthright citizenship after taking charge | No alliance with Congress in Delhi polls: AAP chief Arvind Kejriwal | Bengaluru techie's suicide: Atul Subhash's wife and her family booked | Bengaluru techie's suicide: Atul Subhash's wife and her family booked | INDIA bloc to knock on Supreme Court's doors over alleged EVM manipulation during Maharashtra polls | 'Babri Masjid should be rebuilt in Bengal's Murshidabad': TMC MLA Humayun Kabir sparks row
Merck's Covid pill Molnupiravir out of national treatment protocol for 'major safety concerns': ICMR

Merck's Covid pill Molnupiravir out of national treatment protocol for 'major safety concerns': ICMR

Jan 06, 2022, at 04:36 am

New Delhi/IBNS: Indian Council for Medical Research (ICMR) has cited 'major safety concerns' for not adding Merck's coronavirus pill, Molnupiravir, to the national treatment protocol.